A new study by Tilray Medical, a division of Tilray Brands, shows positive results in using cannabinoid treatments for patients with fibromyalgia. The study, titled ‘Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms: A Case Series (TOMAS),’ examined the impact of Tilray Dried Flower THC18 on chronic pain, sleep, and quality of life. The findings suggest that cannabinoids could be a promising and cost-effective treatment option for fibromyalgia patients.